ESTA
Document
Wednesday, January 14, 2026 BiopharmaWatch Research 1 min read Key Takeaway: Document
Price reaction · baseline $65.13 (2026-01-13 close) · hit after-hours · clean, no other ESTA news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceCash runway
~12 mo
Low dilution risk
Lead asset
Mesenchymal stem cells
Phase 1 · Chronic Myocardial Ischemia
Full Press Release Details